Victor Chigozie | Pharmaceutical Biotechnology | Best Researcher Award

Posted on by ScienceFather

Dr. Victor Chigozie | Pharmaceutical Biotechnology | Best Researcher Award

Dr. Victor Chigozie, David Umahi Federal University of Health Sciences, Nigeria

Dr. Chigozie Victor Uchenna is a Lecturer I at David Umahi Federal University of Health Sciences, Uburu, Ebonyi State, Nigeria, where he also serves as the acting head of the Department of Pharmaceutical Microbiology and Biotechnology. He completed his Ph.D. in Pharmaceutical Biotechnology from Nnamdi Azikiwe University, Awka, where his research focused on the identification and bioactivities of secondary metabolites from fungi. Dr. Chigozie has extensive teaching and research experience, including in pharmaceutical microbiology, biotechnology, and the study of natural products. His key research areas include bioactive compounds, antimicrobial agents, and cancer therapeutics.

Publication Profile

Orcid

Google Scholar

Educational Background 🎓

Dr. Victor Chigozie holds a Ph.D. in Pharmaceutical Biotechnology from Nnamdi Azikiwe University, Awka, Nigeria, where his research focused on the identification and bioactivities of secondary metabolites from Aspergillus species and Daldinia eschscholtzii found in Mangifera indica and Musa paradisiaca leaves. He graduated with first-class honors (4.69/5.0) in 2021. Dr. Chigozie also completed an M.Sc. in Pharmaceutical Microbiology and Biotechnology at the same university, with research on the quality assessment of tetanus toxoid brands in southeastern Nigeria’s markets, publishing his findings. He holds a B.Sc. in Applied Microbiology with second-class honors (4.12/5.0) and a Senior School Certificate with Upper Credit. 🎓📚🔬

 

Professional Experience 🧑‍🔬

Dr. Victor Chigozie has held several key positions in academic and government institutions, contributing significantly to research and development. As a Lecturer I and Acting Head of Pharmaceutical Microbiology and Biotechnology at David Umahi Federal University of Health Sciences, Ebonyi State, he has been instrumental in coordinating classes, practicals, and research, especially in natural products and pharmaceutical biotechnology. He set up a BSL-2 lab and contributed to the development of practical manuals.

Teaching Experience 📚👨‍🏫

Dr. Victor Chigozie has a rich teaching history, contributing extensively to pharmaceutical sciences. At David Umahi Federal University of Health Sciences, Uburu, he has taught several courses, including Introductory Pharmaceutical Microbiology (PHM 201) and Molecular Biology (PHM 202) since 2022, alongside practicals in both subjects. His expertise extends to Pharmaceutical Microbiology I (PHM 301), Aseptic Processes and Sterilization Technology (PHM 302), and Bioinformatics, Pharmacogenetics, and Pharmacogenomics (PHM 382), all of which he began teaching in 2024. Additionally, he teaches courses on integrated pharmacotherapy and sterile product technology.

 

Awards and Recognitions 🏆🎖️

Dr. Victor Chigozie has received numerous prestigious awards for his contributions to pharmaceutical microbiology and biotechnology. Notably, he was named Top Cite Author by Wiley Publishers for 2022-2023. He also received a Travel Grant Award from the Wuhan Institute of Virology (2023) and the National Foundation for Infectious Diseases (2012). Dr. Chigozie was honored with the Ph.D. Award for being the top of his class at Nnamdi Azikiwe University (2021). Additionally, he won the CBN-NYSC-NDE Venture Prize Competition during his NYSC service for the Best Business Proposal (2010). 🏅📚

 

Research Focus

 

Dr. Victor Chigozie’s research spans a wide array of topics in pharmaceutical microbiology, biotechnology, and public health. His work includes antibiotic resistance, exploring emerging strategies to tackle global health challenges. He has contributed significantly to bioactive compounds and endophytic fungi, studying their potential in antimicrobial, anti-inflammatory, and analgesic activities. His research also delves into pharmacovigilance, self-medication practices, and the role of community pharmacies in healthcare systems. Additionally, Dr. Chigozie investigates biosecurity, biosafety, and differentiated care models for diseases like HIV/AIDS. His focus on indigenous knowledge in managing emerging infectious diseases in Africa highlights his commitment to improving health through both modern science and traditional insights. 🌱💊

 

Publication Top Notes

  • Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace – D Chinemerem Nwobodo, MC Ugwu, C Oliseloke Anie, MTS Al‐Ouqaili, … (Cited by: 405, Year: 2022) 🦠
  • Evaluation of the analgesic, anti-inflammatory and antimicrobial activities of leaf extracts of Breynia nivosa – FA Onyegbule, IO Ilouno, PM Eze, CC Abba, VU Chigozie (Cited by: 19, Year: 2014) 🌿
  • Isolation, identification, and evaluation of biological activities of Daldinia eschscholtzii, an endophytic fungus isolated from the leaves of Musa paradisiaca – V Chigozie, M Okezie, E Ajaegbu, F Okoye, C Esimone (Cited by: 13, Year: 2020) 🍌
  • Bioactivities and HPLC analysis of secondary metabolites of a morphologically identified endophytic Aspergillus fungus isolated from Mangifera indica – VU Chigozie, MU Okezie, EE Ajaegbu, FB Okoye, CO Esimone (Cited by: 11, Year: 2022) 🥭
  • Larvicidal and synergistic potentials of some plant extracts against Aedes aegypti – GT Onah, EE Ajaegbu, CC Ezeagha, VU Chigozie, AM Bello, P Chinelo (Cited by: 3, Year: 2022) 🦟
  • Practice, Risk Perception, and Correlates of Self-Medication Among Pregnant Women in Awka – OOB Anthony Maduka, Daniel U. Eze, Victor U. Chigozie (Cited by: 2, Year: 2024) 💊
  • Community Pharmacies, Extent of Services, and Preparedness for Primary Health Care Policy Implementation in Nigeria from 1980 to 2022: A Narrative Review – M Maureen, DU Eze, OC Clementina, N Monica, VU Chigozie, O Brian O (Cited by: 1, Year: 2024) 🏥
  • Quality Assessment of Some Brands of Tetanus Toxoids Marketed in Open Markets in South-Eastern Nigeria – VU Chigozie, PM Eze, CR Chukwunwejim, CC Abba, CS Nworu, … (Cited by: 1, Year: 2014) 💉
  • Identification of Some Bioactive Compounds from Camellia sinensis as Possible Inhibitors of human epidermal growth factor receptor 2 (HER2) – LN Ebenyi, CBG Egwuom, EM Halilu, AP Obialor, TO Johnson, … (Year: 2024) 🍵
  • Antioxidative, anti-androgenic, and inhibitory activities of ethanolic extract of Annona muricata leaf on sex hormones-induced benign prostate hyperplasia through in vivo and … – DDCBA Lilian N. Ebenyi, Victor U. Chigozie (Year: 2024) 🍃

Alireza Rasouli | Biotechnology | Excellence in Research

Posted on by ScienceFather

Mr. Alireza Rasouli | Biotechnology | Excellence in Research

Mr. Alireza Rasouli, Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran

Based on Mr. Alireza Rasouli’s profile, his research and contributions appear to align well with the criteria for the “Research for Excellence in Research” award.

Publication profile

Strong Academic Background and Specialized Expertise

  • Mr. Rasouli holds a Master’s degree in Microbial Biotechnology and a Bachelor’s degree in Biology, both from Islamic Azad University, Qom Branch. His specialization in microbial metabolic production and extensive research experience indicate a solid academic foundation. 🎓

Diverse and Impactful Research Contributions

  • His research spans multiple areas including single-cell oil production, nanoparticle synthesis, and antimicrobial properties. He has published articles in reputable journals and has a notable focus on the application of biotechnology in health and environmental sciences. His work on the green synthesis of nanoparticles and their biological activities highlights his innovative approach. 🧬

Published Work and Citations

  • Single-cell oil production using low-cost carbon sources by newly isolated Kocuria Y205 – Cited by 3 (2021) 🧪
  • Bio-production of Single-cell Oil by Rhodococcus Erythropolis PTCC 1767 Bacterial using Low-cost Carbon Sources – Cited by 3 (2020) 🧫
  • Green Synthesis, Characterization and Biological activity of Optimized Alfalfa‐Mediated Zirconium Nanoparticles – (2024) 🧪
  • Cytotoxic Effects of Green Synthesis of Zirconium Nanoparticles of Aqueous Clover Extract on Breast Cancer – (2024) 🧫
  • Evaluation of Antimicrobial Properties of Bam Date Kernel Extract and Investigation of the Structure of Extract – (2024) 🧪
  • Evaluation and Comparison of Four Types of Bio-Ceramic Materials AGM MTA, Ortho MTA, Pro root MTA and Cem cement in Oral and Dental Health – (2024) 🦷
  • Novel Biosynthesis and Evaluation Cytotoxic Effect of Tellurium Nano-Particle on Breast Cancer Using Co-Culture of Spirulina and Lentinula Edodes – (2024) 🧬
  • A Brief Review on Laccase Enzyme From the Edible Mushroom Lentinus edodes and its Applications in Decontamination of Antibiotics from Wastewater – (2023) 🌱

Ongoing Research and Future Potential

  • He is currently involved in optimizing industrial bioethanol production and algae-based projects, indicating a commitment to addressing both practical and theoretical aspects of biotechnology. This ongoing research emphasizes his dedication to advancing the field. 🔬

Skills and Collaborative Work

  • His skills include advanced laboratory techniques, bioinformatics, and project management, complemented by his collaborative work in various scientific projects. This versatility and teamwork are essential qualities for research excellence. 🤝

 

Conclusion

Mr. Alireza Rasouli’s robust academic background, impactful research, recent publications, and ongoing projects make him a strong candidate for the “Research for Excellence in Research” award. His work reflects significant contributions to the fields of biology and biotechnology, demonstrating both innovation and practical application.